Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

Similar articles for PubMed (Select 23535315)

1.

Stage IE/IIE extranodal NK/T-cell lymphoma arising in the nasal cavity: analysis of CT findings and their prognostic value.

Kim JY, Lee SW, Lee JH, Suh C, Yoon DH, Lee BJ, Huh J, Choi EK, Kim JH, Song SY, Yoon SM, Kim YS, Kim SS, Park JH, Shin HS, Chang SK, Ahn SD.

Clin Radiol. 2013 Jul;68(7):e384-90. doi: 10.1016/j.crad.2012.11.023. Epub 2013 Mar 25.

PMID:
23535315
2.

[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].

Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.

Ai Zheng. 2006 Apr;25(4):465-70. Chinese.

PMID:
16613682
3.

Extranodal natural killer/T-cell lymphoma, nasal type: clinical and computed tomography findings in the head and neck region.

Hung LY, Chang PH, Lee TJ, Hsu YP, Chen YW, Fu CH, Huang CC.

Laryngoscope. 2012 Dec;122(12):2632-9. doi: 10.1002/lary.23531. Epub 2012 Sep 10.

PMID:
22965840
4.

Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy.

Li YX, Coucke PA, Li JY, Gu DZ, Liu XF, Zhou LQ, Mirimanoff RO, Yu ZH, Huang YR.

Cancer. 1998 Aug 1;83(3):449-56.

PMID:
9690537
5.

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.

Oral Oncol. 2008 Jan;44(1):23-30. Epub 2007 Feb 15.

PMID:
17306611
6.

Extranodal nasal-type NK/T-cell lymphoma: computed tomography findings of head and neck involvement.

Kim J, Kim EY, Lee SK, Kim DI, Kim CH, Kim SH, Choi EC.

Acta Radiol. 2010 Mar;51(2):164-9. doi: 10.3109/02841850903476572.

PMID:
20092373
7.

Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients.

Wang L, Xia ZJ, Huang HQ, Lu Y, Zhang YJ.

Int J Hematol. 2012 Nov;96(5):617-23. doi: 10.1007/s12185-012-1174-y. Epub 2012 Sep 16.

PMID:
22983648
8.

[Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].

Yao B, Li YX, Fang H, Yu ZH, Jin J, Liu XF.

Zhonghua Xue Ye Xue Za Zhi. 2006 Apr;27(4):222-5. Chinese.

PMID:
16875550
9.

Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.

Yoo C, Yoon DH, Jo JC, Yoon S, Kim S, Lee BJ, Huh J, Lee SW, Suh C.

Ann Hematol. 2014 Jun;93(6):995-1000. doi: 10.1007/s00277-014-2015-2. Epub 2014 Jan 19.

PMID:
24441948
10.

Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.

Kim SJ, Kim BS, Choi CW, Choi J, Kim I, Lee YH, Kim JS.

Ann Oncol. 2007 Aug;18(8):1382-7.

11.

Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract.

Huang MJ, Jiang Y, Liu WP, Li ZP, Li M, Zhou L, Xu Y, Yu CH, Li Q, Peng F, Liu JY, Luo F, Lu Y.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):166-74. Epub 2007 Oct 24.

PMID:
17919841
12.

Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.

Tababi S, Kharrat S, Sellami M, Mamy J, Zainine R, Beltaief N, Sahtout S, Besbes G.

Eur Ann Otorhinolaryngol Head Neck Dis. 2012 Jun;129(3):141-7. doi: 10.1016/j.anorl.2011.08.004. Epub 2012 Feb 7.

13.

Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.

Kim SJ, Kim K, Kim BS, Kim CY, Suh C, Huh J, Lee SW, Kim JS, Cho J, Lee GW, Kang KM, Eom HS, Pyo HR, Ahn YC, Ko YH, Kim WS.

J Clin Oncol. 2009 Dec 10;27(35):6027-32. doi: 10.1200/JCO.2009.23.8592. Epub 2009 Nov 2.

14.

Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.

Lee WJ, Jung JM, Won CH, Chang SE, Choi JH, Chan Moon K, Park CS, Huh J, Lee MW.

J Am Acad Dermatol. 2014 Jun;70(6):1002-9. doi: 10.1016/j.jaad.2013.12.023. Epub 2014 Mar 12.

PMID:
24629518
15.
16.

Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type.

Kim TM, Park YH, Lee SY, Kim JH, Kim DW, Im SA, Kim TY, Kim CW, Heo DS, Bang YJ, Chang KH, Kim NK.

Blood. 2005 Dec 1;106(12):3785-90. Epub 2005 Aug 18.

17.

MRI appearances of stage IE/IIE extranodal NK/T-cell lymphoma, nasal type, in the upper aerodigestive tract.

Gu Y, Wu B, Zhang Y, Guo Y, Peng W.

Eur Rev Med Pharmacol Sci. 2014;18(3):404-12.

18.

Nasal NK/T-cell lymphoma: computed tomography and magnetic resonance imaging findings.

Ou CH, Chen CC, Ling JC, Chai JW, Wu CH, Chen WH, Hung HC, Tain-Lee, Ho TL.

J Chin Med Assoc. 2007 May;70(5):207-12.

PMID:
17524998
19.

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.

Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, Yu ZH.

J Clin Oncol. 2006 Jan 1;24(1):181-9. Erratum in: J Clin Oncol. 2006 Jun 20;24(18):2973.

20.

Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy.

Logsdon MD, Ha CS, Kavadi VS, Cabanillas F, Hess MA, Cox JD.

Cancer. 1997 Aug 1;80(3):477-88.

PMID:
9241082
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk